Dashboard
Manage Tickers

MNOV


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-medicinovas-mn-166-combat-als-trial-abstract-accepted-for-poster-presentation-at-35th-alsmnd-symposium
Reported Earlier, MediciNova's MN-166 COMB...
09/10/2024 08:39:09

reported-earlier-medicinovas-mn-166-ibudilast-als-clinical-trial-abstract-accepted-for-presentation-at-2024-neals-annual-meeting
Reported Earlier, MediciNova's MN-166 (Ibu...
09/04/2024 07:23:29

why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Recursion Pharmaceuticals Shares Are T...
09/03/2024 17:41:09

reported-earlier-medicinova-receives-us-patent-allowance-for-mn-166-ensuring-broad-protection-for-post-covid-treatment-through-2042
Reported Earlier, MediciNova Receives U.S....
08/30/2024 07:53:27

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the T...

medicinova-has-received-a-notice-of-allowance-from-the-us-patent-and-trademark-office-for-a-pending-patent-application-covering-mn-166-ibudilast-for-the-prevention-of-metastasis-in-various-cancers
MediciNova Has Received A Notice Of Allowa...
06/05/2024 10:02:06

medicinova-presents-new-data-and-results-of-phase-1b2a-clinical-trial-of-mn-166-at-asco-meeting
MediciNova Presents New Data And Results O...
06/03/2024 10:03:29

The highlights of presentation are as follows: The primary endpoints were safety and tolerability of MN-166 and TMZ combinatio...

medicinova-receives-notice-of-allowance-from-us-pto-for-pending-patent-application-which-covers-mn-166-ibudilast-for-prevention-of-metastasis-of-eye-cancer
MediciNova Receives Notice Of Allowance Fr...
05/20/2024 10:04:25

medicinova-receives-notice-of-allowance-for-new-patent-covering-mn-166-ibudilast-for-chlorine-induced-acute-respiratory-distress-syndrome-once-issued-this-patent-is-expected-to-expire-no-earlier-than-january-2042
MediciNova Receives Notice Of Allowance Fo...
05/14/2024 10:15:00

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/05/2024 20:31:09

reported-earlier-medicinova-announces-abstract-regarding-results-of-a-clinical-trial-of-mn-166-in-glioblastoma-accepted-for-presentation-at-the-2024-asco
Reported Earlier, Medicinova Announces Abs...
04/03/2024 06:45:26

Abstract Number: 2106 Title:  Phase 1b/2a study evaluating the combination of MN-166 (ibudilast) and temozolomide in patients ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 13:05:57

why-mariadb-shares-are-trading-higher-by-around-100-here-are-20-stocks-moving-premarket
Why MariaDB Shares Are Trading Higher By A...
03/27/2024 12:14:28

Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announce...

reported-earlier-medicinova-receives-notice-of-allowance-from-japan-patent-office-for-mn-166-in-macular-injury-treatment
Reported Earlier, MediciNova Receives Noti...
03/27/2024 06:40:38

Once issued, this patent is expected to expire no earlier than October 2039.  The allowed claims cover the use of MN-166 (ibudi...

reported-earlier-medicinova-announces-two-abstracts-regarding-mn-001-and-mn-002-accepted-for-presentation-at-the-92nd-eas-2024-congress
Reported Earlier, MediciNova Announces Two...
03/21/2024 07:14:03

 MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...

medicinova-announces-new-data-and-results-of-mn-166-ibudilast-in-chlorine-gas-induced-acute-lung-injury-presented-at-the-annual-meeting-of-the-society-of-toxicology
MediciNova Announces New Data and Results ...
03/12/2024 10:36:39

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 13:06:18

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/16/2024 13:06:00

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/13/2024 13:06:00

medicinova-secures-notice-of-grant-for-new-patent-covering-mn-166-ibudilast-for-treatment-of-macular-injury-in-china
MediciNova Secures Notice Of Grant For New...
01/17/2024 11:03:00

medicinova-says-abstract-regarding-mn-166-ibudilast-in-chlorine-gas-induced-lung-injury-accepted-for-presentation-at-the-63rd-annual-meeting-of-the-society-of-toxicology
MediciNova Says Abstract Regarding MN-166 ...
12/21/2023 23:04:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION